Q. Ning, M. Han, Y. Sun, J. Jiang, D. Tan et al., Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial), Journal of Hepatology, vol.61, issue.4, pp.777-784, 2014.
DOI : 10.1016/j.jhep.2014.05.044

Q. Ning, M. Han, Y. Sun, J. Jiang, D. Tan et al., Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial), Journal of Hepatology, vol.61, issue.4, pp.583-588, 2014.
DOI : 10.1016/j.jhep.2014.05.044

R. Adam, A. Laurent, D. Azoulay, D. Castaing, and H. Bismuth, Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors, Annals of Surgery, vol.232, issue.6, pp.777-785, 2000.
DOI : 10.1097/00000658-200012000-00006

G. Vennarecci, A. Laurenzi, R. Santoro, M. Colasanti, P. Lepiane et al., The ALPPS Procedure: A Surgical Option for Hepatocellular Carcinoma with Major Vascular Invasion, World Journal of Surgery, vol.193, issue.6, pp.1498-1503, 2014.
DOI : 10.1007/s00268-013-2296-y

E. Schadde, V. Ardiles, K. Slankamenac, C. Tschuor, G. Sergeant et al., ALPPS Offers a Better Chance of Complete Resection in Patients with Primarily Unresectable Liver Tumors Compared with Conventional-Staged Hepatectomies: Results of a Multicenter Analysis, World Journal of Surgery, vol.252, issue.5, pp.1510-1519, 2014.
DOI : 10.1007/s00268-014-2513-3

G. Vennarecci, A. Laurenzi, L. Sandri, G. , B. Rizzi et al., The ALPPS procedure for hepatocellular carcinoma, European Journal of Surgical Oncology (EJSO), vol.40, issue.8, pp.748-798300397, 2014.
DOI : 10.1016/j.ejso.2014.04.002

W. Hofmann, J. Rädle, C. Moench, W. Bechstein, and S. Zeuzem, Pr??diktion der perioperativen Mortalit??t bei Patienten mit fortgeschrittener Lebererkrankung und abdominalchirurgischen Eingriffen anhand unterschiedlicher Score- und Testsysteme, Zeitschrift f??r Gastroenterologie, vol.46, issue.11, pp.1283-1289, 2008.
DOI : 10.1055/s-2008-1027624

S. Teh, J. Christein, J. Donohue, F. Que, M. Kendrick et al., Hepatic Resection of Hepatocellular Carcinoma in Patients With Cirrhosis: Model of End-Stage Liver Disease (MELD) Score Predicts Perioperative Mortality, Journal of Gastrointestinal Surgery, vol.9, issue.9, pp.1207-1215, 2005.
DOI : 10.1016/j.gassur.2005.09.008

A. Cucchetti, G. Ercolani, M. Vivarelli, M. Cescon, M. Ravaioli et al., Is Portal Hypertension a Contraindication to Hepatic Resection?, Annals of Surgery, vol.250, issue.6, pp.922-928, 2009.
DOI : 10.1097/SLA.0b013e3181b977a5

R. Santambrogio, M. Kluger, M. Costa, A. Belli, M. Barabino et al., Hepatic resection for hepatocellular carcinoma in patients with Child???Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?, HPB, vol.15, issue.1, pp.78-84, 2013.
DOI : 10.1111/j.1477-2574.2012.00594.x

J. Shi, E. Lai, N. Li, W. Guo, J. Xue et al., A new classification for hepatocellular carcinoma with portal vein tumor thrombus, Journal of Hepato-Biliary-Pancreatic Sciences, vol.6, issue.1, pp.74-80, 2011.
DOI : 10.1007/s00534-010-0314-0